These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 22710899)

  • 21. Cutaneous B-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.
    Hristov AC; Tejasvi T; Wilcox RA
    Am J Hematol; 2020 Oct; 95(10):1209-1213. PubMed ID: 32815650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome.
    Golling P; Cozzio A; Dummer R; French L; Kempf W
    Leuk Lymphoma; 2008 Jun; 49(6):1094-103. PubMed ID: 18569636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
    Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD
    J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indurated Plaques on the Legs: Think Lymphoma.
    Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma.
    Lang CCV; Ramelyte E; Dummer R
    Front Oncol; 2020; 10():1163. PubMed ID: 32850331
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of primary cutaneous B-cell lymphomas].
    Zenahlik P; Fink-Puches R; Kapp KS; Kerl H; Cerroni L
    Hautarzt; 2000 Jan; 51(1):19-24. PubMed ID: 10663035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous B-cell lymphomas. Current concepts. I.
    Santucci M; Pimpinelli N
    Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL).
    Martínez-Banaclocha N; Martínez-Madueño F; Caballé B; Badia J; Blanes M; Bujanda DA; Calvo V; Gómez Codina J; Blanco CQ; Espinosa P; Lavernia J; Arroyo FRG; Risueño MG; Llorca C; Cumeras R; Pulla MP; Gumà J
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
    Koens L; Vermeer MH; Willemze R; Jansen PM
    Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary cutaneous B-cell lymphoma: review and current concepts.
    Pandolfino TL; Siegel RS; Kuzel TM; Rosen ST; Guitart J
    J Clin Oncol; 2000 May; 18(10):2152-68. PubMed ID: 10811681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification.
    Bessell EM; Humber CE; O'Connor S; English JS; Perkins W; Dickinson PD; Patel AN
    Br J Dermatol; 2012 Nov; 167(5):1118-23. PubMed ID: 22759204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
    Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
    Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
    Lucioni M; Berti E; Arcaini L; Croci GA; Maffi A; Klersy C; Goteri G; Tomasini C; Quaglino P; Riboni R; Arra M; Dallera E; Grandi V; Alaibac M; Ramponi A; Rattotti S; Cabras MG; Franceschetti S; Fraternali-Orcioni G; Zerbinati N; Onida F; Ascani S; Fierro MT; Rupoli S; Gambacorta M; Zinzani PL; Pimpinelli N; Santucci M; Paulli M
    Cancer Med; 2016 Oct; 5(10):2740-2755. PubMed ID: 27665744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
    Mao X; Orchard G
    Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas.
    Krenitsky A; Klager S; Hatch L; Sarriera-Lazaro C; Chen PL; Seminario-Vidal L
    Am J Clin Dermatol; 2022 Sep; 23(5):689-706. PubMed ID: 35854102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
    Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
    J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-CD20 antibodies in primary cutaneous B-cell lymphoma. Initial results in dermatologic patients].
    Gellrich S; Muche JM; Pelzer K; Audring H; Sterry W
    Hautarzt; 2001 Mar; 52(3):205-10. PubMed ID: 11284065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary Cutaneous B-Cell Lymphomas: An Update.
    Vitiello P; Sica A; Ronchi A; Caccavale S; Franco R; Argenziano G
    Front Oncol; 2020; 10():651. PubMed ID: 32528871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.